| Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Post … C Rebordosa, RW Thomsen, AK Tave, M Madsen, DC Beachler, ... Diabetes, Obesity and Metabolism 26 (4), 1291-1304, 2024 | | 2024 |
| IDF23-0079 Cardiorenal Events in Medication-Initiator Cohorts of Patients with Chronic Kidney Disease and Type 2 Diabetes in Japan N Kashihara, H Kanegae, S Okami, NG Oberprieler, M Pladevall-Vila, ... Diabetes Research and Clinical Practice 209, 111136, 2024 | | 2024 |
| # 2505 CHARACTERISTICS OF MEDICATION-INITIATOR COHORTS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES IN JAPAN: A REPORT FROM FOUNTAIN PLATFORM Y Yano, H Kanegae, S Okami, N Oberprieler, M Pladevall-Vila, A Gay, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_2505, 2023 | | 2023 |
| Post-authorization safety studies of acute liver injury and severe complications of urinary tract infection in patients with type 2 diabetes exposed to dapagliflozin in a real … HE Danysh, CB Johannes, DC Beachler, JB Layton, R Ziemiecki, A Arana, ... Drug safety 46 (2), 175-193, 2023 | 1 | 2023 |
| Post-authorization safety study of hospitalization for acute kidney injury in patients with type 2 diabetes exposed to Dapagliflozin in a real-world setting CB Johannes, DC Beachler, JB Layton, HE Danysh, R Ziemiecki, A Arana, ... Drug safety 46 (2), 157-174, 2023 | 3 | 2023 |
| Validation of acute outcomes among patients with type 2 diabetes mellitus in the clinical practice research datalink HE Danysh, A Gilsenan, A Arana, M Pladevall-Vila, JB Layton, ... Pharmacoepidemiol Drug Saf 30 (S1), 393-4, 2021 | 2 | 2021 |
| Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis PK Foreman, AV Margulis, K Alexander, R Shediac, B Calingaert, ... Orphanet Journal of Rare Diseases 16 (1), 253, 2021 | 19 | 2021 |
| Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis K Alexander, A Margulis, P Foreman, R Shediac, B Calingaert, A Harding, ... Molecular Genetics and Metabolism 132, S112, 2021 | | 2021 |
| Description of acute kidney injury and breast cancer outcome validation processes across three databases J Dinh, HE Danysh, C Johannes, L Gutierrez, R Schmid, A Arana, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 571-571, 2020 | | 2020 |
| Validation of acute outcomes among patients with type 2 diabetes mellitus in medicare: a pilot study HE Danysh, JB Layton, DC Beachler, A Arana, M Pladevall-Vila, ... Pharmacoepidemiol Drug Saf 29 (Suppl 3), 396, 2020 | 2 | 2020 |
| Validity of hospital ICD‐10‐GM codes to identify acute liver injury in Germany A Timmer, D de Sordi, S Kappen, KP Kohse, T Schink, S Perez‐Gutthann, ... Pharmacoepidemiology and Drug Safety 28 (10), 1344-1352, 2019 | 10 | 2019 |
| Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer … CK Zhou, J Dinh, HE Danysh, C Johannes, L Gutierrez, R Schmid, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 157-158, 2019 | 3 | 2019 |
| Antidepressant use in Denmark, Germany, Spain, and Sweden from 2009 to 2014: Incidence and comorbidities of antidepressant initiators J Forns, A Pottegard, T Reinders, B Poblador-Plou, R Morros, L Brandt, ... Pharmacoepidemiology and Drug Safety 28, 274-275, 2019 | | 2019 |
| Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: A study in three European data sources J Forns, M Cainzos‐Achirica, M Hellfritzsch, R Morros, B Poblador‐Plou, ... Pharmacoepidemiology and drug safety 28 (7), 965-975, 2019 | 23 | 2019 |
| Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources J Castellsagué, E Jacquot, M Pladevall-Vila, R Morros, M Giner-Soriano, ... Wiley Online Library, 2019 | | 2019 |
| Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: incidence and comorbidities of antidepressant initiators J Forns, A Pottegård, T Reinders, B Poblador-Plou, R Morros, L Brandt, ... Journal of affective disorders 249, 242-252, 2019 | 64 | 2019 |
| Risk of acute liver injury in agomelatine and other antidepressant users in four European countries: a cohort and nested case–control study using automated health data sources M Pladevall-Vila, A Pottegård, T Schink, J Reutfors, R Morros, ... CNS drugs 33, 383-395, 2019 | 23 | 2019 |
| Validity of ICD-9 and ICD-10 codes used to identify acute liver injury J Forns, M Cainzos-Achirica, M Hellfritzsch, R Morros, B Poblador-Plou, ... | | 2019 |
| Agomelatine and Other Antidepressants and the Risk of Acute Liver Injury, a Post-Authorisation Safety Study in 4 European Countries M Pladevall, A Pottegård, T Schink, J Reutfors, R Morros, B Poblador-Plou, ... | | 2019 |
| Communication issues in nutritional observational research M Cainzos-Achirica, U Bilal, M Al Rifai, JW McEvoy, RS Blumenthal, ... Preventive medicine 115, 76-82, 2018 | 10 | 2018 |